Hydrogen Sulfide Donors Activated by Reactive Oxygen Species
- 24 October 2016
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 55 (47) , 14638-14642
Abstract
Hydrogen sulfide (H2S) exhibits promising protective effects in many (patho)physiological processes, as evidenced by recent reports using synthetic H2S donors in different biological models. Herein, we report the design and evaluation of compounds denoted PeroxyTCM, which are the first class of reactive oxygen species (ROS)‐triggered H2S donors. These donors are engineered to release carbonyl sulfide (COS) upon activation, which is quickly hydrolyzed to H2S by the ubiquitous enzyme carbonic anhydrase (CA). The donors are stable in aqueous solution and do not release H2S until triggered by ROS, such as hydrogen peroxide (H2O2), superoxide (O2−), and peroxynitrite (ONOO−). We demonstrate ROS‐triggered H2S donation in live cells and also demonstrate that PeroxyTCM‐1 provides protection against H2O2‐induced oxidative damage, suggesting potential future applications of PeroxyTCM and similar scaffolds in H2S‐related therapies.Keywords
This publication has 43 references indexed in Scilit:
- Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That BlossomedPhysiological Reviews, 2012
- Selective turn-on fluorescent probes for imaging hydrogen sulfide in living cellsChemical Communications, 2012
- Hydrogen sulfide-mediated myocardial pre- and post-conditioningExpert Review of Clinical Pharmacology, 2011
- Cysteine-Activated Hydrogen Sulfide (H2S) DonorsJournal of the American Chemical Society, 2010
- Hydrogen sulfide and ischemia–reperfusion injuryPharmacological Research, 2010
- Novel Insights Into Hydrogen Sulfide–Mediated CytoprotectionAntioxidants & Redox Signaling, 2010
- Hydrogen sulfide mediates the vasoactivity of garlicProceedings of the National Academy of Sciences, 2007
- Hydrogen sulphide and its therapeutic potentialNature Reviews Drug Discovery, 2007
- Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammationThe FASEB Journal, 2006
- The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel openerThe EMBO Journal, 2001